# Capital Medical University: Not applicable (device, behavioral) study closed enrollment, 438 enrolled (Ischemic Stroke, Atrial Fibrillation)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Capital Medical University |
| Sponsor type | Academic and hospital |
| Study | Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation |
| NCT ID | NCT07139301 |
| Phase | Not applicable (device, behavioral) |
| Status | active not recruiting |
| Conditions | Ischemic Stroke; Atrial Fibrillation |
| Intervention types | drug |
| Target enrollment | 438 |
| Site countries | China |
| Posted | 2025-08-24 |
| Planned start | 2025-09-04 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-11-03 |
| Last update posted | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Enrollment closed: data management, monitoring and closeout ahead.
- 438 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07139301). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.